Global Next-Generation Sequencing Industry and Projected to Reach US$ 16.35 Billion Growing at CAGR 19.2% to 2024

Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg) are the key players operating in the global next-generation sequencing market. A majority of the leading players in this market are adopting the strategies of product launches and upgrades, partnerships and collaborations, and acquisitions to further enhance their market positions.

Click Here for Complete Report on Next-Generation Sequencing (NGS) Market at http://www.rnrmarketresearch.com/next-generation-sequencing-ngs-market-by-platforms-hiseq-miseq-hiseq-x-ten-x-five-nextseq500-ion-proton-pgm-ions5-pacbio-sequel-services-targeted-sequencing-de-novo-application-diagnostic-drug-ts-to-2021-market-report.html .
215 Pages 13 Profiling 96 Tables 35 Figures

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%.

Premium Insights
1 Next-Generation Sequencing (NGS): Market Overview
2 NGS Market, By Product & Service, 2018 vs 2024
3 NGS Market, By Technology, 2018 vs 2024 (USD Million)
4 NGS Market, By Application, 2018 vs 2024 (USD Million)
5 NGS Market, By End User and Region, 2018

Click Here for Free Sample Papers at http://www.rnrmarketresearch.com/contacts/request-sample?rname=507635 .

Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics are expected to propel the growth of this market.

Stakeholders
1 NGS equipment manufacturers, vendors, and distributors
2 NGS sequencing service companies
3 NGS bioinformatics/data analysis companies
4 Research laboratories and academic institutes
5 Venture capitalists and other government funding organizations
6 Research and consulting firms
7 Healthcare institutions (hospitals and diagnostic clinics)
8 Pharmaceutical and biotechnology companies
9 Contract manufacturing organizations (CMOs)
10 Contract research organizations (CROs)

Click Now for More Details on “Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=507635 .

This report studies the next-generation sequencing market based on product & service, technology, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type: Tier 1 - 40%, Tier 2 - 25%, and Tier 3 - 36%
• By Designation: C-level - 43%, Director-level - 22%, and Others - 35%
• By Region: North America - 37%, Europe - 12%, APAC - 41%, and RoW -10%

Purchase this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=507635 .

Contact:
sales@rnrmarketresearch.com / Call +1 888 391 5441
RnRMarketResearch Provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.